Wang et al. reported that a median dose of 60 Gy delivered to the mediastinum of 72 non-small cell lung carcinoma patients was associated with a significant increase in peripheral CD8+ T-cells [30]. Here, CD8A is linked to non-small cell lung carcinoma.